CD47 and osteoporosis: Taken together, these findings demonstrate that CD47 antibody can mitigate ageing‐related and osteoporosis‐associated bone loss by promoting osteoblast activity, reducing adipocyte accumulation, and suppressing osteoclast activity (Figure 9).